Relationship between bronchial hyperreactivity and bronchodilation in patients with allergic rhinitis

Annals of Allergy, Asthma and Immunology

Volumn 106, Issue 6, 2011, Pages 460-466

  Ciprandi, Giorgio ^a   Signori, Alessio ^b   Cirillo, Ignazio ^c  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c Navy Medical Service   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALLERGIC RHINITIS; ARTICLE; BRONCHODILATATION; BRONCHUS HYPERREACTIVITY; DISEASE MARKER; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY FLOW; FORCED VITAL CAPACITY; HUMAN; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; ALBUTEROL; ASTHMA; BRONCHI; BRONCHIAL HYPERREACTIVITY; BRONCHIAL PROVOCATION TESTS; BRONCHODILATOR AGENTS; CROSS-SECTIONAL STUDIES; FEMALE; FORCED EXPIRATORY FLOW RATES; FORCED EXPIRATORY VOLUME; HUMANS; INFLAMMATION; MALE; METHACHOLINE CHLORIDE; MIDDLE AGED; RHINITIS, ALLERGIC, PERENNIAL; RISK FACTORS; SPIROMETRY; VITAL CAPACITY; YOUNG ADULT;

EID: 79957903287     PISSN: 10811206     EISSN: 15344436     Source Type: Journal    
DOI: 10.1016/j.anai.2011.03.001     Document Type: Article

References (29)

1. Bousquet J, Khaltaev N, Cruz AA, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 Update (in collaboration with the World Health Organization, GA2LEN and AllerGen). Allergy. 2008;63:S8-160.
2. Asher I. ISAAC International Study of Asthma and Allergies in Childhood. Pediatr Pulmonol. 2007;42:100. (Pubitemid 46080162)
3. Plaschke PP, Janson C, Norrman E, et al. Onset and remission of allergic rhinitis and asthma and the relationship with atopic sensitization and smoking. Am J Respir Crit Care. 2000;162:920-924.
4. Braunstahl GJ, Kleinjan A, Overbeek SE, Prins JB, Hoogsteden HC, Fokkens WJ. Segmental bronchial provocation induces nasal inflammation in allergic rhinitis patients. Am J Respir Crit Care Med. 2000;161: 2051-2057. (Pubitemid 30418150)
5. Braunstahl GJ, Overbeek SE, Fokkens WJ, et al. Segmental bronchoprovocation in allergic rhinitis patients affects mast cell and basophil numbers in nasal and bronchial mucosa. Am J Respir Crit Care Med. 2001;164:858-865. (Pubitemid 32881925)
6. Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J. 2005;26:948-968. (Pubitemid 41632054)
7. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J. 2005;26:319-338. (Pubitemid 41079078)
8. Bacharier LB, Mauger DT, Lemanske RF, Schend V, Sorkness C, Strunk RC. Classifying asthma severity in children: is measuring lung function helpful? J Allergy Clin Immunol. 2002;109:S266.
9. Bjermer L. Past and future perspectives in the asthma treatment. Respir Med. 2001;95:703-719.
10. Lipworth BJ, Clark DJ. Effects of airway calibre on lung delivery of nebulised salbutamol. Thorax. 1997;52:1016-1021.
11. Ciprandi G, Cirillo I, Vizzaccaro A, et al. Seasonal and perennial allergic rhinitis: is this classification adherent to real life? A population based study. Allergy. 2005;60:882-887. (Pubitemid 40813809)
12. Wallace DV, Dykewicz MS. The diagnosis and management of rhinitis: An updated practice parameter. J Allergy Clin Immunol. 2008;122: S1-84.
13. 1/forced vital capacity ratio in relation to clinical and physiological parameters in asthmatic children with normal FEV1 values. J Allergy Clin Immunol. 2010;126: 527-534.
14. Katelaris CH. Allergic rhinitis and asthma: epidemiological evidence for the link. Clin Exp All Rev. 2003;3:5-8.
15. Townley RG, Ryo UY, Kolotkin BM, Kang B. Bronchial sensitivity to methacholine in current and former asthmatic and allergic rhinitis patients and control subjects. J Allergy Clin Immunol. 1975;56:429-442.
16. Braman SS, Barrows AA, DeCotis BA. Airways hyper-responsiveness in allergic rhinitis: A risk factor for asthma. Chest. 1987;91:671-674. (Pubitemid 17069162)
17. Verdiani P, Di Carlo S, Baronti A. Different prevalence and degree of nonspecific bronchial hyperreactivity in rhinitis. J Allergy Clin Immunol. 1990;86:576-582. (Pubitemid 20372519)
18. Cirillo I, Klersy C, Vizzaccaro A, Pallestrini E, Tosca M, Ciprandi G. Role of FEF 25%-75% as a predictor of bronchial hyperreactivity in allergic patients. Ann Allergy Asthma Immunol. 2006;96:692-700.
19. 25%-75% might be a predictive factor. Allergy Asthma Proc. (in press)
20. Dreborg S, ed. EAACI Subcommittee on Skin Tests. Skin tests used in type I allergy testing. Position paper. Allergy. 1989;44:S22-S31.
21. American Thoracic Society. Guiedelines for Methacholine and Exercise Challenge Testing-1999. Am J Resp Crit Care Med. 2000;161:309-329.
22. Guerra S, Sherrill DL, Martinez FD, Barbee RA. Rhinitis as an independent risk factor for adult-onset asthma. J Allergy Clin Immunol. 2002;109:419-425. (Pubitemid 34234190)
23. Shaaban R, Zureik M, Soussan D, et al. Rhinitis and onset of asthma: a longitudinal population-based study. Lancet. 2008;372:1049-1057.
24. 25%-75% as an early marker of bronchial impairment in patients with seasonal allergic rhinitis. Am J Rhinol. 2006;20:641-647.
25. Ciprandi G, Cirillo I, Klersy C. Lower airways are affected also in asymptomatic patients with recent onset of allergic rhinitis. Laryngoscope. 2010;120:1288-1291.
26. Ciprandi G, Cirillo I, Pistorio A. Impact of allergic rhinitis on asthma: effects on spirometric parameters. Allergy. 2008;63:255-260. (Pubitemid 351224670)
27. Cirillo I, Pistorio A, Tosca MA, Ciprandi G. Impact of allergic rhinitis on asthma: effects on bronchial hyperreactivity. Allergy. 2009;64: 439-444.
28. Ciprandi G, Cirillo I, Pistorio A, La Grutta S, Tosca MA. Impact of allergic rhinitis on asthma: effects on bronchodilation test. Annals Allergy Asthma Immunol. 2008;101:42-46. (Pubitemid 352000743)
29. Ciprandi G, Buscaglia S, Pesce GP, et al. Minimal persistent inflammation is present at mucosal level in asymptomatic rhinitic patients with allergy due to mites. J Allergy Clin Immunol. 1995;96:971-978.